THE Department of Health has published a summary setting out the biosimilar brands of medicines which have been approved by the Therapeutic Goods Administration and subsidised on the Pharmaceutical Benefits Scheme.
PBS approved items include epoetin lambda, filgrastim, infliximab, follitropin alfa and etanercept - see health.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Dec 17
